This drugs company has seen no estimate revision over the past 30 days while its Zacks Consensus Estimate has moved down over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Ohr Pharmaceutical has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some stocks in the same industry looking equally good include POZEN Inc. (POZN), Aerie Pharmaceuticals, Inc. (AERI) and Ariad Pharmaceuticals Inc. (ARIA). While POZEN holds a Zacks Rank #1 (Strong Buy), Aerie Pharmaceuticals and Ariad Pharmaceuticals carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment